Brain's Frontal Lobes Electric Activity Disrupted by COVID-19
A Glimpse into the Brain's Struggle with COVID-19
According to recent research, patients with neurological symptoms associated with COVID-19 often exhibit unique abnormalities in their brain activity, as revealed by electroencephalography (EEG) tests. This essay provides an overview of these findings and their implications.
Coronavirus Data hunger for knowledge drives us to delve into the most recent data and statistics on COVID-19. As you can imagine, some figures may lose their relevance over time. For the most up-to-date information on the virus, feel free to visit our coronavirus hub.
Estimates suggest that somewhere between 15-25% of individuals with severe COVID-19 exhibit neurological symptoms such as headaches, confusion, intellectual impairment, seizures, and strokes. These patients may require EEG tests to monitor the electrical activity of their brains.
Researchers from Baylor College of Medicine in Houston, TX, and the University of Pittsburgh, PA, analyzed EEG findings from 617 patients across 84 different studies, aiming to understand the impact of COVID-19 on the brain. The median age of participants was 61.3 years, and two-thirds were male.
Abnormal Findings up Front
Approximately a third of the discovered abnormalities were located in the frontal lobes of the brain. Dr. Zulfi Haneef, an assistant professor of neurology and neurophysiology at Baylor, notes that the frontal lobe is situated next to the most likely entry point for the virus – the nose.
"We need to try EEG on a wider range of patients, as well as other types of brain imaging, such as MRI or CT scans, to get a closer look at the frontal lobe," asserts Dr. Haneef.
It is essential to recognize that the virus may not be the sole culprit for all the observed damage. Systemic effects of the infection, such as inflammation, low oxygen levels, thickened blood, and cardiac arrest, might also contribute to EEG abnormalities that extend beyond the frontal lobes.
Brain Fog: A Lasting Impact?
Some recovered COVID-19 patients continue to experience lingering health problems, now known as long COVID. One such issue is cognitive impairment, or "brain fog."
A recent study, not yet peer-reviewed, demonstrated that individuals who believe they have contracted COVID-19 performed worse on an online cognitive test compared to those who did not think they had the virus. According to experts, this cross-sectional study does not definitively prove that the infection caused long-term cognitive decline, but it does raise concerns about potential lasting effects on the brain.
"These findings suggest that there might be long-term issues that we haven't previously been aware of," confirms Dr. Haneef, adding to the growing body of evidence that warrants further research and concern. On the brighter side, 56.8% of patients showed improvements in their EEG results following follow-up tests.
**For live updates on the latest advancements concerning the novel coronavirus and COVID-19, click here.
**Enrichment Data**:
Common EEG Abnormalities in COVID-19 with Neurological Symptoms- Generalized Slowing: Many patients exhibit prolonged slowing, often represented by generalized theta or delta activity, associated with encephalopathy or delirium commonly observed in severe COVID-19 cases.- Focal Abnormalities: Some patients may show localized slowing or epileptiform discharges, especially if they have focal neurological deficits or seizures.- Periodic Discharges: Rare cases may present with periodic discharges, observed in encephalitis or other severe neurological complications, and are more frequent in severe cases, often linked with a poorer prognosis.- Non-convulsive Seizure Activity: Reports have surfaced of non-convulsive status epilepticus in severely ill COVID-19 patients, highlighting the importance of EEG monitoring for individuals with unexplained altered mental status.
Correlation with Disease Severity- Mild to Moderate COVID-19: Patients with mild neurological symptoms (such as headache, anosmia, or mild cognitive complaints) typically have normal EEGs or only minor, non-specific abnormalities.- Severe COVID-19 and Encephalopathy: Patients manifesting encephalopathy, confusion, or severe cognitive decline are more likely to present with significant EEG abnormalities, such as generalized or focal slowing, and sometimes epileptiform discharges. These findings are associated with adverse clinical outcomes and extended hospital stays.- Extreme Severity (Encephalitis, Prolonged Seizures): Cases of COVID-19-induced encephalitis or persistent seizures may exhibit periodic discharges or other severe EEG abnormalities, which can indicate a high risk of morbidity and mortality.
Impact of Pre-existing Neurological Conditions- Patients with Pre-existing Neurological Conditions: Individuals with prior history of epilepsy, dementia, or cerebrovascular disease face a higher risk of developing severe neurological complications and may exhibit more pronounced EEG abnormalities, like heightened seizure activity or more severe background slowing.- Risk of New-Onset Neurological Disorders: COVID-19 can trigger the onset of new neurological conditions, such as seizures, Parkinsonian symptoms, or cognitive decline, which might be reflected in subsequent EEG findings. The risk of such events is elevated in patients with prior neurological or psychiatric histories.
Summary Table| EEG Abnormality | Typical COVID-19 Severity | Pre-existing Neurological Condition Impact ||--------------------------|--------------------------|------------------------------------------------|| Generalized slowing | Moderate-severe | More pronounced in pre-existing encephalopathy || Focal abnormalities | Variable | Increased with focal lesions or epilepsy || Periodic discharges | Severe | Higher risk in pre-existing neurological issues || Non-convulsive seizures | Severe | Increased risk with prior epilepsy |
Key Points- EEG abnormalities are more prevalent and severe in patients with severe COVID-19 or pre-existing neurological conditions.- Generalized slowing is the most frequent abnormality, but focal disruptions and seizures (including non-convulsive) are also documented.- Pre-existing neurological conditions increase the risk of severe EEG abnormalities and new-onset neurological disease following COVID-19.
These findings underscore the importance of EEG monitoring in COVID-19 patients with neurological symptoms, particularly those with severe disease or pre-existing neurological risk factors.
- The study on COVID-19 patients with neurological symptoms indicates a connection between the coronavirus and epilepsy seizures, Word's Disease, and neurological disorders, all of which relate to health-and-wellness and mental-health.
- In some severe COVID-19 cases, cognitive impairment, or 'brain fog,' persists after recovery, overlapping with topics like nutrition and aging, crucial aspects within the realm of health-and-wellness.
- The investigation into the impact of COVID-19 on the brain includes a variety of brain imaging techniques, such as MRI or CT scans, which align with the field of science and environmental-science.
- The frontal lobes of the brain exhibit the most significant number of abnormalities related to COVID-19, which falls within the scope of neurological-disorders, health-and-wellness, and brain-related scientific endeavors.
- Quite often, the observed brain damage isn't attributed solely to the virus; factors like inflammation, low oxygen levels, thickened blood, and cardiac arrest may also contribute, emphasizing the significance of understanding the interplay between coronavirus and other health issues, including fitness-and-exercise.
- CBD, a possible solution for managing certain health conditions according to some research, might be beneficial for managing COVID-19-induced neurological symptoms, connecting the topic with medical-conditions, health-and-wellness, mental-health, and science.
- Meanwhile, the long-term implications of COVID-19 on the brain and cognitive function remain a topic of concern for the scientific community, particularly in relation to space-and-astronomy, as understanding neurological diseases might be necessary for future space travel and its impact on human health.
